Syreon Research Institute

🌟 Syreon Day 2024, a full day of insightful discussions, project highlights, and collaborative workshops focused on future research projects, and the transformative power of AI in our work. 🌟   With colleagues joining from different locations around the world, this event was a unique opportunity to bring everyone in one place, strengthening our team and thinking together. By exchanging insights from different research areas, we developed a stronger understanding of each field, including best practices, challenges, recent developments, and new directives We were also joined by external experts, like Laszlo Balkanyi, who provided insights into the evolving landscape of Artificial Intelligence (AI).    The day concluded with an engaging AI workshop, where our colleagues tackled real-world problems in small groups and explored how AI can drive innovative solutions. This hands-on experience offered insight into the possibilities and limitations of such emerging technologies.    Syreon Day 2024 was a great opportunity to connect, learn and explore the latest advancements in our fields while enjoying time together as a team. We’re excited to see where our shared experiences and insights will take us next! 

💊Medication non-adherence: reflecting on two decades since the WHO adherence report and setting goals for the next twenty years Non-adherence to medication remains a persistent and significant challenge, with profound implications for patient outcomes and the long-term sustainability of healthcare systems. Our colleagues, Krisztina Toth and Tamas Agh, have recently co-authored an article aimed at identifying the most important progress made over the last two decades in medication adherence management and initiating a discussion on future objectives, including priority targets for the next 20 years. 💡The study's findings call for a paradigm shift, presenting ten suggestions across a number of dimensions. These advocate for repositioning medication adherence on national agendas and highlight the necessity of creating an adherence-supportive ecosystem going beyond mere patient support. 👉 Read the full article here: https://lnkd.in/dk4rMDWW #MedicationAdherence #AdherenceSupport #MedicalResearch #InnovationInHealthcare #PharmaResearch #CollaborativeCare #Healthcare #Pharma #PatientCare #Medicine #HealthPolicy #SustainableHealthcare #PublicHealth

Universal Health Coverage (UHC) Day 2024 Universal Health Coverage Day is an official United Nations-designated day marking the anniversary of the unanimous endorsement of UHC in 2012 as an essential priority for international development. An incremental move towards universal health coverage (UHC) is an important issue, particularly in developing countries.    Our colleagues, Zoltán Kaló and Balázs Nagy, co-authored a study in 2020 titled “Supporting Role of Non-Governmental Health Insurance Schemes in the Implementation of Universal Health Coverage in Developing Countries.”  Experts argue that the nature of health insurance arrangements provided outside of governmental schemes strongly depends on the structure and evolution of the publicly funded system, as well as the extent to which regulators allow non-governmental healthcare actors to support it. There is often limited fiscal capacity for UHC implementation, which can result in restricted access to healthcare and high out-of-pocket payments. An important policy question is whether health insurance provided by non-governmental actors—whether on a non-profit or for-profit basis—can support UHC implementation to resolve these challenges. Collaboration between public and private stakeholders is important to facilitate UHC implementation, supported by supplementary and complementary health insurance schemes. Read the full article here:   https://lnkd.in/dcRaMYZk  #UHCDay2024 #HealthcareForAll #UHCDay #HealthcareRights #PublicHealth 

Tradeoffs When Building and Running Cohort and Patient-Level Markov Simulation Models    In this recent study, written as part of the Horizon Europe-funded Immutol project, experts compared cohort (CH) and patient-level (PL) Markov modeling techniques within a cost-effectiveness analysis framework, which aligns with IMMUTOL’s objective to decrease healthcare costs and enhance patients’ quality of life.    While CH models process average patient cohorts, PL models simulate individual patient pathways, offering greater flexibility but requiring more technical expertise and computational resources. The choice between these modeling approaches is not straightforward, and while numerous conceptual and practical differences have been discussed, understanding the practical trade-offs between them is essential.    The paper was co-authored by Syreon Research Institute colleagues Balázs Nagy, Zoltán Kaló, Rok Hren, and Bertalan Németh who played a key role in designing and evaluating the Markov simulation models.    The study highlights key trade-offs between cohort (CH) and patient-level (PL) approaches, demonstrating how CH models offer stability and transparency, while PL models excel in capturing complex patient pathways and subgroup analyses. These insights – demonstrating the importance of weighing flexibility, detail, and resource optimization when selecting a modeling approach - help refine health economic modeling, supporting Immutol’s broader scientific, economic, and social goals.    Read the full article to explore these practical insights in greater depth:  https://lnkd.in/dJ7Fr_3q      #MarkovModeling #CostEffectiveness #SimulationModels #HealthEconomics #SyreonResearchInstitute #Immutol

November 13-án a Magyar Egészség-gazdaságtani Társaság (META)-gal és a Syreon Research Institute-tal közösen rendeztük meg idei utolsó eseményünket, az emlőrák társadalmi keretrendszeréről szóló kutatás társadalmi egyeztető fórumát. A kutatóközpont munkatársai azt vizsgálták, hogy a különböző érintett társadalmi szereplők számára melyek azok a tényezők és értékelemek, amelyek az emlőrákkal kapcsolatos döntéseiket befolyásolják. Dr. Bidló Judit, a Belügyminisztérium egészségügy szakmai irányításáért felelős helyettes államtitkára a kezdeményezés kapcsán azt hangsúlyozta, hogy az emlőrák kiemelt figyelmet kap, a nagy társadalmi ismertség és elfogadás miatt pedig ezen a területen „olyan adatok és módszertanok is nyerhetőek, amelyek a későbbiek folyamán más betegségek elleni küzdelemben is felhasználhatóak”, példaként említve a betegút szervezésének területét. Az Egészség Hídja fontosnak tartja az egyeztetések szerepét a megoldandó feladatok megoldásába. A megalakuló emlőrák koalíció mérföldkő a hazai mellrák elleni küzdelemben. Lehetővé teszi, hogy egyesítsük erőinket és tudásunkat a betegek érdekében, és hatékonyabban tudjunk fellépni a megelőzés, a korai felismerés és a terápiás lehetőségek területén is, részben azzal, hogy ajánlásokat fogalmazunk meg a mellrákkal érintett betegek ellátásának további fejlesztésére. Köszönjük Reka Pozsar Dalma Hosszú Anna Bögös Zoltán Kaló a gondolatébresztő eredmények mellett azt, hogy az ész mellett szíveteket és lelketeket beletettétek a kutatásba. Külön köszönet András Harsányi azért ,hogy aktívan dolgozik a magyar betegszervezetek láthatóságának növelésén.

Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE’s key recommendations    The ageing population, staff shortages, and economic constraints have put significant pressure on European health systems. Poor medication adherence alone results in 200,000 premature deaths and €125 billion of wasted costs annually. Digital adherence technologies hold promise in addressing this challenge. While adoption accelerated during the COVID-19 pandemic, barriers such as privacy concerns and reimbursement policies remain significant.    To tackle these challenges, the ENABLE Adherence (European Network to Advance Best Practices and Technology on Medication Adherence) project was launched under the COST Action framework in 2020. Over four years, ENABLE’s extensive collaboration across 40 countries mapped the barriers and facilitators for medication adherence management and developed resources such as a publicly accessible repository of digital adherence technologies. It also explored reimbursement pathways key for broader adoption. Syreon Research Institute played an active role in ENABLE, with Tamas Agh leading a working group focusing on the sustainable implementation of digital adherence technologies.    ENABLE’s final dissemination event “World Adherence Forum” took place in August 2024 in Brussels, in the presence of relevant organisations and stakeholders, such as the World Health Organization, patient organisations, healthcare professionals, medtech and pharmaceutical companies. During the meeting, the main findings were discussed, placed in the broader context of Europe’s health system resilience, and key recommendations were developed to address persistent challenges in medication adherence.     To learn more about ENABLE’s key recommendations, read the full article, which has just been published in The Lancet Regional Health - Europe: https://lnkd.in/dsNnnJjg      #ENABLE #DigitalAdherence #MedicationAdherence #HealthInnovation #HealthSystemResilience #Sustainability

Did you know that XR technology traces its roots to an invention nearly 200 years ago? Today, this revolutionary field has reached new heights, finding applications across multiple sectors, including healthcare. 🩺 Europe’s XR ecosystem is steadily evolving, with Germany 🇩🇪, the United Kingdom 🇬🇧, and France  🇫🇷 leading in both the number of XR companies and the revenue generated by XR activities. However, due to market entry barriers and regulatory challenges, these innovative solutions remain difficult to access for doctors and patients across the European Union. With the VR Health Champions project, we are on a mission to change that by providing targeted support to our five flagship SMEs, while also expanding the European healthcare XR ecosystem through knowledge transfer and funding opportunities.   What do you think about the potential of XR in healthcare? Let us know in the comments! 👇 🌐✨ Visit our website to stay connected https://lnkd.in/dBsXFWc2 Source: https://lnkd.in/gaiak4D Klaster LifeScience Krakow Fondazione Bruno Kessler - FBK Medical University of Lodz, Lodz University of Technology University of Latvia (Latvijas Universitāte) Centro Hospitalar e Universitário de Coimbra (CHUC) Medtronic Syreon Research Institute, RTE Lab, XR4Europe, Instituto Pedro Nunes EIT Health InnoStars #VRHealthChampions #XR4Healthcare #BridgingTechGap #I3

🚀 ISPOR Europe 2024 – November 17–20, Barcelona, Spain Congratulations to our colleagues who represented Syreon Research Institute at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024 last week! This year, our team members participated in a variety of sessions at the annual conference. 💡Highlights included: 📌 Two successful ISPOR Forum Sessions that covered the subjects of the Implementation of Needed Novel HTA Methodologies in National and EU HTA Practice & SUSTAIN-HTA and the Current Regulations and Best Practices for Defining, Measuring, and Reporting Medication Adherence in Clinical Trials. Learn more about the Forum Sessions here: 🔗 https://lnkd.in/dbWmrgEF  🔗 https://lnkd.in/dbbaunTj 📌14 Poster presentations that showcased recent research conducted by Syreon colleagues, featuring works of our talented young professionals and PhD students: Stefánia Plankó, Attila Imre PharmD, ThanhTu Nguyen and said wani.    Thank you to all the co-authors, partners, and colleagues for their invaluable contributions. #ISPOREurope #ISPOR #HTA #HealthTechnologyAssessment #MedicationAdherence #HorizonEurope 

Our colleagues will showcase Syreon Research Institute’s latest research at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024 in Barcelona, Spain, from Nov 17-20. Join us at the two ISPOR Forum sessions, including one on Health Technology Assessment (HTA) methodologies & SUSTAIN-HTA and another on medication adherence. Additionally, explore our poster presentations covering topics from the economic burden of diseases to innovative HTA models. 💡Learn more about our presentations here: https://lnkd.in/d8uWVp-Y #ISPOREurope #ISPOR #HTA #HealthTechnologyAssessment #MedicationAdherence

On October 7th, GE HealthCare launched Thera4Care, an initiative focused on expanding the use of theranostics in Europe. This €25.3 million project unites 29 partners from leading European academic and clinical sites, patient advocacy groups, and innovative small and medium-sized enterprises, including Syreon Research Institute. Thera4Care aims to innovate cancer treatment by integrating advanced imaging diagnostics with targeted therapeutics, offering a more personalized and precise approach. By standardizing scalable methods for theranostic isotope production and use, this collaboration aims to broaden patient access and improve healthcare outcomes across Europe. Syreon is thrilled to be part of this project, contributing to the development of more efficient, accessible, and compassionate treatment solutions for cancer patients. #Thera4Care #IHI